H.Res. 95: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a “Valley of Death” in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.

Introduced:

Feb 5, 2015

Status:

Referred to Committee on Feb 5, 2015

This resolution was assigned to a congressional committee on February 5, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.

Sponsor:

Juan Vargas

Representative for California's 51st congressional district

Democrat

Text:

Read Text »
Last Updated: Feb 5, 2015
Length: 4 pages

Prognosis:

3% chance of being agreed to (details)

About the resolution

Read CRS Summary >

History

Feb 5, 2015
 
Introduced

This is the first step in the legislative process.

 
Reported by Committee

 
Agreed To

This page is about a resolution in the United States Congress. A simple resolution is used for matters that affect just one chamber of Congress, often to change the rules of the chamber to set the manner of debate for a related bill. It must be agreed to in the chamber in which it was introduced. It is not voted on in the other chamber and does not have the force of law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: